Old Web
English
Sign In
Acemap
>
Paper
>
Use of Clinical, Surrogate, and Intermediate End Points in Randomized Controlled Fontan Trials
Use of Clinical, Surrogate, and Intermediate End Points in Randomized Controlled Fontan Trials
2019
K. Ten
Ingo Germund
Moritz Haustein
M. Khalil
P. Koopman
Christian Apitz
L. Duijnhouwer
Michael Huntgeburth
Konrad Brockmeier
A. Helbing
U. Herberg
Narayanswami Sreeram
B. Tanke
G. Kerst
A. Udink
Keywords:
Surgery
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]